KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Deferred Tax Liability (2020 - 2024)

BioNTech SE's Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $45.3 million for Q4 2024.

  • For Q4 2024, Non-Current Deferred Tax Liability rose 6.07% year-over-year to $45.3 million; the TTM value through Dec 2024 reached $45.3 million, up 6.07%, while the annual FY2024 figure was $45.9 million, 6.86% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2024 was $45.3 million at BioNTech SE, up from $42.7 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $76.3 million in Q4 2021 and bottomed at $238458.0 in Q4 2020.
  • The 5-year median for Non-Current Deferred Tax Liability is $42.7 million (2023), against an average of $34.2 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability surged 31898.45% in 2021 before it crashed 91.71% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $238458.0 in 2020, then soared by 31898.45% to $76.3 million in 2021, then crashed by 91.71% to $6.3 million in 2022, then surged by 575.28% to $42.7 million in 2023, then grew by 6.07% to $45.3 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Non-Current Deferred Tax Liability are $45.3 million (Q4 2024), $42.7 million (Q4 2023), and $6.3 million (Q4 2022).